NCT07505849 2026-04-01
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
Henan Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT07191249 2025-09-24
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
Phase 2 Not yet recruiting
NCT06362707 2024-10-22
FEAD
Helse Stavanger HF
Phase 2 Recruiting